Oculis Holding AG (OCS) Capital Expenditures (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Capital Expenditures of -$8939.0 in Q1 2026, up 81.2% quarter-over-quarter from -$47544.5 in Q4 2025, and up 38.18% on a YoY basis from -$6469.2 in Q1 2025.

Oculis Holding AG (OCS) Capital Expenditures (2022 - 2026) Analysis & Trends

Oculis Holding AG's Capital Expenditures history runs 5 years deep, the most recent figure standing at -$8939.0 for Q1 2026.

  • In Q1 2026, Capital Expenditures rose 38.18% year-over-year to -$8939.0; the TTM figure through Mar 2026 stood at -$363691.2 (down 38.33% YoY), while the FY2025 annual figure was -$376602.1, down 43.44% from the prior year.
  • Capital Expenditures was -$8939.0 for Q1 2026 at Oculis Holding AG, up from -$47544.5 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of -$5636.8 in Q4 2023 to a low of -$177747.9 in Q3 2024.
  • Historically, Capital Expenditures has averaged -$63064.4 across 5 years, with a median of -$31063.7 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Capital Expenditures soared 61.21% in 2023, then plunged 1054.33% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at -$14532.3 in 2022, then jumped by 61.21% to -$5636.8 in 2023, then slumped by 1054.33% to -$65066.7 in 2024, then climbed by 26.93% to -$47544.5 in 2025, then surged by 81.2% to -$8939.0 in 2026.
  • The last three Capital Expenditures figures came in at -$8939.0 (Q1 2026), -$47544.5 (Q4 2025), and -$155013.6 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Alterity Therapeutics 860,679.92 Bn 860,679.89 Bn - -
2 Belite Bio 55,284.00 Bn 55,284.00 Bn - -
3 Quantum Biopharma 16,206.94 Bn 16,206.93 Bn - -
4 Legend Biotech 3,318.00 Bn 3,317.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,543.84 Bn 1,543.84 Bn - -
6 Evaxion A 1,449.11 Bn 1,449.09 Bn - -
7 Psyence Biomedical 216.99 Bn 216.98 Bn - -
8 Vertex Pharmaceuticals 115.22 Bn 107.97 Bn 2.59 Bn 133.40 Mn
9 Abivax 90.58 Bn 90.58 Bn - -63,220.27
10 Oculis Holding AG 8.45 Bn 8.15 Bn - -8,939.03

Historic Data

Download Data
DateValue
Mar 31, 2026 -8,939.03
Mar 31, 2026 -8,939.03
Dec 31, 2025 -47,544.45
Dec 31, 2025 -47,544.45
Sep 30, 2025 -155,013.58
Sep 30, 2025 -155,013.58
Jun 30, 2025 -152,194.17
Jun 30, 2025 -152,194.17
Mar 31, 2025 -14,459.26
Mar 31, 2025 -14,459.26
Dec 31, 2024 -65,066.75
Dec 31, 2024 -65,066.75
Sep 30, 2024 -177,747.92
Sep 30, 2024 -177,747.92
Dec 31, 2023 -5,636.77
Dec 31, 2023 -5,636.77
Sep 30, 2023 -21,510.90
Sep 30, 2023 -21,510.90
Dec 31, 2022 -14,532.31
Dec 31, 2022 -14,532.31